Home » Topics » Disease categories and therapies » Infection

Infection
RSS

Carbapenems in development at Korean research institute characterized at ICAAC

Sep. 30, 1998

SYN-2869: new triazole antifungal agent selected for further development

Sep. 30, 1998

Pyrrole antiviral agents prepared and evaluated at Rhone-Poulenc Rorer

Sep. 30, 1998

Nyotran effective against treatment-resistant fungal infections in phase II study

Sep. 30, 1998

Novel series of 1beta-methylcarbapenems under evaluation at Banyu

Sep. 29, 1998

New 8-methoxyquinolone selected for development at Daiichi

Sep. 29, 1998

Data presented at ICAAC indicate efficacy of Sch-56592 in leishmaniasis and phaeohyphomycosis

Sep. 29, 1998

In vivo efficacy and toxicity studies presented at ICAAC for T-3811ME

Sep. 29, 1998

Profile of new carbapenem antibiotic selected for activity against resistant pathogens

Sep. 29, 1998

Cubist presents favorable efficacy data for daptomycin at ICAAC

Sep. 29, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...